CIK 0001815776 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
LENZ Therapeutics, Inc.
Sign in to watch- Ticker
- LENZ
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844867570
- Phone
- 858-925-7000
- Business address
- 201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
- Former names
- Graphite Bio, Inc.
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- UPLOAD Other SEC-generated Letter
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- S-4 Deal Registration Statement - Business Combination
- SC 13D/A Stake Beneficial Ownership Report
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 8-K/A Event Executive or director change
- 8-K Event Exit or restructuring costs · Executive or director change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
Page 11 of 18 · 359 filings